Keyphrases
Acute Ischemic Stroke
50%
Arterial Injury
16%
AS605240
27%
Bacterial Infection
14%
Blood-brain Barrier Disruption
31%
Brain Hemorrhage
31%
CD147
86%
CD40
54%
Combination Treatment
14%
Denudation
15%
Embolic Stroke
42%
Endoplasmic Reticulum Stress (ER stress)
27%
Experimental Stroke
44%
Focal Cerebral Ischemia
15%
Functional Recovery
21%
Infarct Volume
23%
Inflammation
35%
Inflammatory Cells
16%
Inflammatory Response
22%
Intracerebral Hemorrhage
18%
Intravenous Tissue Plasminogen Activator
15%
Ischemia
26%
Ischemic Brain
14%
Ischemic Brain Injury
24%
Ischemic Stroke
100%
J147
27%
Leukocyte Recruitment
14%
Lung
22%
Matrix metalloproteinase-9 (MMP-9)
15%
Microglial Activation
14%
Mouse Model
16%
Neointima Formation
65%
Neurological Deficit
15%
Patency
16%
Phosphoinositide 3-kinase (PI3K)
95%
Platelet Activation
17%
Platelets
28%
Protective Effect
17%
Skin Carcinogenesis
15%
Spleen
17%
Therapeutic Target
16%
Thrombolytic Therapy
22%
Tissue Plasminogen Activator (t-PA)
84%
Transient Middle Cerebral Artery Occlusion (tMCAO)
48%
Traumatic Brain Injury
41%
Vascular Injury
15%
Vascular Remodeling
14%
Vascular Smooth muscle Cells
22%
Vascular Thrombosis
33%
White Matter Integrity
13%
Medicine and Dentistry
Acetyl-CoA
9%
Apolipoprotein
7%
Apoplexy
19%
Atherosclerosis
14%
Bleeding
13%
Blood Brain Barrier
17%
Blood Vessel Injury
15%
Brain Ischemia
20%
Carboxylase
9%
Carcinogen
7%
Carcinogenesis
17%
CD40 Ligand
8%
Cell Migration
16%
Cerebral Ischemia-Reperfusion Injury
13%
Embolic Stroke
13%
Experimental Stroke
15%
Focal Adhesion Kinase
13%
Gelatinase B
6%
Immune Response
15%
In Vitro
10%
Infarction
11%
Inflammatory Cell
5%
Integrin
13%
Intercellular Adhesion Molecule 1
6%
Ischemia
9%
Leukocyte
11%
Leukocyte Recruitment
14%
Lung
13%
Neointima
42%
Oxidative Stress
18%
Phosphoinositide 3-Kinase
41%
Phosphotransferase
13%
Platelet
34%
Programmed Cell Death
5%
Signaling Protein
13%
Skin Carcinogenesis
27%
Skin Tumor
13%
Smooth Muscle Cell
17%
Superoxide
6%
Thrombocyte Activation
19%
Thrombosis
32%
Tissue Plasminogen Activator
13%
Transcription Factor RUNX2
13%
Uncoupling Protein 2
13%
Upregulation
19%
Vascular Remodeling
14%
Vascular Smooth Muscle Cell
43%
Pharmacology, Toxicology and Pharmaceutical Science
Acetyl-CoA
9%
Artery Injury
13%
Atherosclerosis
13%
Bacterial Infection
13%
Bleeding
13%
Blood Vessel Injury
13%
Brain Hemorrhage
18%
Brain Ischemia
38%
Carboxylase
9%
Carcinogen
7%
Carcinogenesis
17%
CD40 Ligand
10%
Cerebrovascular Accident
51%
Combination Therapy
6%
Experimental Stroke
30%
Fibrinolytic Agent
21%
Gelatinase B
5%
Infarction
12%
Inflammatory Disease
6%
Intercellular Adhesion Molecule 1
6%
Ischemia
5%
Knockout Mouse
6%
Malignant Neoplasm
7%
Matrix Metalloproteinase
20%
microRNA 29a
13%
Middle Cerebral Artery Occlusion
11%
Mouse
13%
Mouse Model
15%
Nanocarrier
5%
Neointima
27%
Phosphatidylinositol 3 Kinase
13%
Phosphotransferase
13%
Rat Model
13%
Shikonin
13%
Side Effect
5%
Simvastatin
13%
Skin Carcinogenesis
27%
Skin Tumor
13%
Superoxide
7%
Taurine
6%
Thrombosis
29%
Tissue Plasminogen Activator
68%
Traumatic Brain Injury
13%
Tumor Necrosis Factor Receptor Associated Factor 6
7%
Uncoupling Protein 2
13%
Wild Type Mouse
10%
